Olanzapine for Injection

Camber Pharmaceuticals, Inc.

Revision date : 2023-05-18

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS05
Health risk rating 4
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

87-69-4

Name of the chemical

L-(+)-tartaric acid

Concentration

N/A

EC/CAS

7647-01-0

Name of the chemical

Hydrochloric acid

Concentration

N/A

EC/CAS

1310-73-2

Name of the chemical

sodium hydroxide

Concentration

N/A

General Information

Revision date

2023-05-18

Product name

Olanzapine for Injection

Manufacturer Name

Aspiro Pharma Limited

Icons in SDS

GHS05

Company Information

company name

Camber Pharmaceuticals, Inc.

Hazard Codes

Hazard statements (CLP)

H302, H317, H318

Hazard statements

Code

Statements

H302

Harmful if swallowed

Section 2

SECTION 2: Hazards identification

Hazard statements

May form combustible dust concentrations in air. Harmful if swallowed. May cause an allergic skin reaction. Causes serious eye damage.

Precautionary statements

Avoid breathing vapors, mist, or spray. Wash hands, forearms, and other exposed areas thoroughly after handling. Do not eat, drink or smoke when using this product. Contaminated work clothing must not be allowed out of the workplace. Wear protective gloves, protective clothing, and eye protection. If swallowed: Call a poison center or doctor if you feel unwell. If on skin: Wash with plenty of water If in eyes: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a poison center or doctor Rinse mouth. If skin irritation or rash occurs: Get medical advice/attention. Take off contaminated clothing and wash it before reuse. Dispose of contents/container in accordance with local, regional, national, and international regulations.

2.3 Other hazards

Exposure may aggravate those with pre-existing eye, skin, or respiratory conditions. Therapeutic use has resulted in the following adverse effects: sleepiness, weight gain, increases in serum prolactin, dizziness, weakness, restlessness, increase appetite, swelling of hands and feet, decreased blood pressure when standing, dry mouth and constipation Overdose of the drug has resulted in changes in heart rate and rhythm, slurred speech, reduced level of consciousness ranging from sedation to coma.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.